Management tracks

The Pharmaceutical Research and Manufacturers of America (PhRMA) elected five new board members. They are Werner Baumann, chairman of the board of management at the Bayer HealthCare AG subsidiary of Bayer AG (Xetra:BAYN); Giovanni Caforio, CEO of Bristol-Myers Squibb Co. (NYSE:BMY); Peter Greenleaf, CEO of Sucampo Pharmaceuticals Inc. (NASDAQ:SCMP); Ramona Sequeira, president of the Takeda Pharmaceutical USA Inc. subsidiary of Takeda Pharmaceutical Co. Ltd. (Tokyo:4502); and Timothy Walbert, chairman, president and CEO of Horizon Pharma plc (NASDAQ:HZNP).

AstraZeneca plc (LSE:AZN; NYSE:AZN) named Pam Cheng EVP of operations and IT. Cheng was president of the MSD China unit of Merck & Co. Inc. (NYSE:MRK). ...